US Bancorp
PRVA icon

US Bancorp’s Privia Health PRVA Stock Holding History

US Bancorp’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Sell
4,031
-5,311
-57% -$123K ﹤0.01% 2436
2026
Q1 		$192K Sell
9,342
-5,316
-36% -$120K ﹤0.01% 2045
2025
Q4 		$348K Sell
14,658
-5,965
-29% -$145K ﹤0.01% 1737
2025
Q3 		$514K Buy
20,623
+4,141
+25% +$89.1K ﹤0.01% 1485
2025
Q2 		$379K Sell
16,482
-2,005
-11% -$46.4K ﹤0.01% 1648
2025
Q1 		$415K Buy
18,487
+429
+2% +$9.97K ﹤0.01% 1594
2024
Q4 		$353K Buy
18,058
+1,134
+7% +$22.5K ﹤0.01% 1700
2024
Q3 		$308K Sell
16,924
-2,419
-13% -$46.2K ﹤0.01% 1794
2024
Q2 		$336K Buy
19,343
+1,111
+6% +$19.7K ﹤0.01% 1727
2024
Q1 		$357K Sell
18,232
-3,290
-15% -$69.5K ﹤0.01% 1697
2023
Q4 		$496K Buy
21,522
+483
+2% +$10.8K ﹤0.01% 1497
2023
Q3 		$484K Buy
21,039
+135
+0.6% +$3.43K ﹤0.01% 1393
2023
Q2 		$546K Buy
20,904
+5,404
+35% +$143K ﹤0.01% 1356
2023
Q1 		$428K Buy
15,500
+2,900
+23% +$76.6K ﹤0.01% 1482
2022
Q4 		$286K Sell
12,600
-361
-3% -$10K ﹤0.01% 1669
2022
Q3 		$442K Sell
12,961
-932
-7% -$34.5K ﹤0.01% 1448
2022
Q2 		$405K Sell
13,893
-30
-0.2% -$763 ﹤0.01% 1545
2022
Q1 		$372K Buy
13,923
+1,131
+9% +$26.7K ﹤0.01% 1668
2021
Q4 		$331K Buy
+12,792
New +$319K ﹤0.01% 1747
2021
Q3 		– Sell
-228
Closed -$10K – 4160
2021
Q2 		$10K Buy
+228
New +$8.41K ﹤0.01% 3400

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

US Bancorp's PRVA Position: Q2 2026 in Review

US Bancorp reduced its Privia Health (PRVA) stake by 57% in Q2 2026, selling an estimated $123K and leaving 4,031 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2436.

US Bancorp first reported a position in PRVA in Q2 2021 and has held it in 20 quarters since. The position peaked at $546K in Q2 2023. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • US Bancorp held 4,031 shares of Privia Health worth $104K as of Q2 2026.
  • US Bancorp sold 5,311 Privia Health shares in Q2 2026, an estimated $123K.
  • Privia Health made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2436 holding.
  • US Bancorp first reported a position in Privia Health in Q2 2021 and has held it in 20 quarters since.
  • US Bancorp's Privia Health position peaked at $546K in Q2 2023.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.